Results 281 to 290 of about 2,554,961 (312)
Some of the next articles are maybe not open access.
Sumoylation in neurodegenerative diseases
Cellular and Molecular Life Sciences, 2012The yeast SUMO (small ubiquitin-like modifier) orthologue SMT3 was initially discovered in a genetic suppressors screen for the centromeric protein Mif2 (Meluh and Koshland in Mol Bio Cell 6:793-807, 1). Later, it turned out that the homologous mammalian proteins SUMO1 to SUMO4 are reversible protein modifiers that can form isopeptide bonds with lysine
Petranka, Krumova, Jochen H, Weishaupt
openaire +2 more sources
Ageing and neurodegenerative diseases
Ageing Research Reviews, 2010Ageing, which all creatures must encounter, is a challenge to every living organism. In the human body, it is estimated that cell division and metabolism occurs exuberantly until about 25 years of age. Beyond this age, subsidiary products of metabolism and cell damage accumulate, and the phenotypes of ageing appear, causing disease formation.
Chia-Wei, Hung +4 more
openaire +2 more sources
Cannabinoids and Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets, 2009Although significant advances have taken place in recent years on our understanding of the molecular mechanisms of different neurodegenerative diseases, its translation into effective therapeutic treatments has not been as successful as could be expected.
J, Romero, J Martínez, Orgado
openaire +2 more sources
Glaucoma as a Neurodegenerative Disease
Journal of Neuro-Ophthalmology, 2015The primary pathophysiological feature of glaucoma is a progressive optic neuropathy with characteristic morphological changes of the optic disc and risk factors of age and intraocular pressure. Recently, involvement of other areas of the central nervous system (CNS) beyond the optic nerve has been demonstrated.
Helen V, Danesh-Meyer, Leonard A, Levin
openaire +2 more sources
Biomarkers in Neurodegenerative Diseases
2017The past decade has seen tremendous efforts in biomarker discovery and validation for neurodegenerative diseases. The source and type of biomarkers has continued to grow for central nervous system diseases, from biofluid-based biomarkers (blood or cerebrospinal fluid (CSF)), to nucleic acids, tissue, and imaging.
Andreas, Jeromin, Robert, Bowser
openaire +2 more sources
AMPK in Neurodegenerative Diseases
2016Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are neurodegenerative disorders that are characterized by a progressive degeneration of nerve cells eventually leading to dementia. While these diseases affect different neuronal populations and present distinct clinical features, they share in common ...
Manon, Domise, Valérie, Vingtdeux
openaire +2 more sources
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases
Current Neuropharmacology, 2022Sean Leng
exaly